Cargando…

Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell Lymphoma

Background: Natural killer/T-cell lymphoma (NKTCL) is a highly aggressive lymphoma with a dismal prognosis, and novel therapeutic targets are urgently needed. Programmed death-ligand 1 (PD-L1) has become a promising therapeutic target for various cancers, but most of the studies have focused on expr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xue-wen, Bi, Xi-wen, Liu, Pan-pan, Liu, Ze-long, Nie, Man, Yang, Hang, Lei, De-xin, Xia, Yi, Jiang, Wen-qi, Zeng, Wei-an
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424071/ https://www.ncbi.nlm.nih.gov/pubmed/32850435 http://dx.doi.org/10.3389/fonc.2020.01360

Ejemplares similares

Consolidative treatment after salvage chemotherapy improves prognosis in patients with relapsed extranodal natural killer/T-cell lymphoma
por: Nie, Man, et al.
Publicado: (2016)

The Role of PD-L1 Expression in Prediction and Stratification of Recurrent or Refractory Extranodal Natural Killer/T-Cell Lymphoma
por: Gao, Li-Min, et al.
Publicado: (2022)

Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group
por: Liu, Weiping, et al.
Publicado: (2021)

PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma
por: Bi, Xi-wen, et al.
Publicado: (2016)

High Pretreatment D-Dimer Levels Correlate with Adverse Clinical Features and Predict Poor Survival in Patients with Natural Killer/T-Cell Lymphoma
por: Bi, Xi-wen, et al.
Publicado: (2016)

Phase II Study of Gemcitabine, Peg-Asparaginase, Dexamethasone and Methotrexate Regimen for Newly Diagnosed Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Final Analysis With Long-Term Follow-Up and Rational Research for the Combination
por: Wang, Yu, et al.
Publicado: (2022)

How to Identify Patients at High Risk of Developing Nasal-Type, Extranodal Nature Killer/T-Cell Lymphoma-Associated Hemophagocytic Syndrome
por: Li, Na, et al.
Publicado: (2021)

Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding
por: Althoff, Ashley, et al.
Publicado: (2017)

Non-coding RNAs in Natural Killer/T-Cell Lymphoma
por: Mei, Mei, et al.
Publicado: (2019)

Oncogenic Network and Hub Genes for Natural Killer/T-Cell Lymphoma Utilizing WGCNA
por: Liu, Huijiao, et al.
Publicado: (2020)

Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma
por: Huang, Jia-Jia, et al.
Publicado: (2013)

Integrated driver mutations profile of chinese gastrointestinal-natural killer/T-cell lymphoma
por: Li, Shanshan, et al.
Publicado: (2022)

Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma
por: Cai, Qingqing, et al.
Publicado: (2019)

The Effect of Chronic Rhinosinusitis on the Staging and Prognosis of Extranodal Natural Killer/T-Cell Lymphoma: A Single-Center Retrospective Analysis
por: Lei, Tingting, et al.
Publicado: (2022)

The pretreatment albumin to globulin ratio predicts survival in patients with natural killer/T-cell lymphoma
por: Bi, Xi-wen, et al.
Publicado: (2016)

Combination of Anti-PD-1 Antibody, Anlotinib and Pegaspargase “Sandwich” With Radiotherapy in Localized Natural Killer/T Cell Lymphoma
por: Sun, Peng, et al.
Publicado: (2022)

Correlation between the clinicopathological features and prognosis in patients with extranodal natural killer/T cell lymphoma
por: Zeng, Lin-Shu, et al.
Publicado: (2017)

Aspirin Inhibits Natural Killer/T-Cell Lymphoma by Modulation of VEGF Expression and Mitochondrial Function
por: Zhang, Hongyu, et al.
Publicado: (2019)

In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas
por: Kim, Jin Ju, et al.
Publicado: (2023)

Tim-3 Blockade Elicits Potent Anti-Multiple Myeloma Immunity of Natural Killer Cells
por: Jiang, Wen, et al.
Publicado: (2022)

Prognostic significance of the systemic immune-inflammation index in patients with extranodal natural killer/T-cell lymphoma
por: Hai, Tao, et al.
Publicado: (2023)

Lymphocyte/Monocyte Ratio is a Novel Predictor for Early Stage Extranodal Natural Killer/T-cell Lymphoma, Nasal Type
por: Wang, Qiao-xuan, et al.
Publicado: (2017)

Cuproptosis-related genes score: A predictor for hepatocellular carcinoma prognosis, immunotherapy efficacy, and metabolic reprogramming
por: Nie, Guilin, et al.
Publicado: (2023)

VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma
por: He, Hai-Xia, et al.
Publicado: (2021)

Prognostic Nutritional Index, Another Prognostic Factor for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type
por: Yao, Ningning, et al.
Publicado: (2020)

Increased percentage of PD-L1(+) natural killer cells predicts poor prognosis in sepsis patients: a prospective observational cohort study
por: Jiang, Wenqiang, et al.
Publicado: (2020)

Further investigation of blockade effects and binding affinities of selected natural compounds to immune checkpoint PD-1/PD-L1
por: Li, Huifang, et al.
Publicado: (2022)

Clinical Features, Diagnosis, Management and Prognosis of Primary Intraocular Lymphoma
por: Zhao, Xin-yu, et al.
Publicado: (2022)

Extranodal natural killer/T-cell lymphoma invading a patient’s heart: A rare case report and literature review
por: Xiang, Yifei, et al.
Publicado: (2022)

The Clinical Utility of Circulating Epstein-Barr Virus DNA Concentrations in NK/T-Cell Lymphoma: A Meta-Analysis
por: Liu, Ze-Long, et al.
Publicado: (2018)

In vitro Natural Killer Cell Immunotherapy for Medulloblastoma
por: Fernández, Lucia, et al.
Publicado: (2013)

CDC27 Promotes Tumor Progression and Affects PD-L1 Expression in T-Cell Lymphoblastic Lymphoma
por: Song, Yue, et al.
Publicado: (2020)

An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma
por: Ferrarini, Isacco, et al.
Publicado: (2023)

Corrigendum: CDC27 Promotes Tumor Progression and Affects PD-L1 Expression in T-Cell Lymphoblastic Lymphoma
por: Song, Yue, et al.
Publicado: (2021)

Characteristics, Prognostic Factors, and Survival of Patients with NK/T-Cell Lymphoma of Non-upper Aerodigestive Tract: A 17-Year Single-Center Experience
por: Liu, Ze-Long, et al.
Publicado: (2019)

Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer/T-cell lymphoma in vivo and in vitro
por: Liu, Wen-jian, et al.
Publicado: (2018)

Neurolymphomatosis Caused by Nasal-type Extranodal Natural Killer/T-cell Lymphoma
por: Yi, Fang-Fang, et al.
Publicado: (2017)

Mutation Profiling of Malignant Lymphoma by Next-Generation Sequencing of Circulating Cell-Free DNA
por: Sun, Peng, et al.
Publicado: (2019)

Flow Cytometry-Assessed PD1/PDL1 Status in Tumor-Infiltrating Lymphocytes: A Link With the Prognosis of Diffuse Large B-Cell Lymphoma
por: Chen, Zihang, et al.
Publicado: (2021)

Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma
por: Cai, Jun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_20lhdsaf2mqmi74rjp2osdkqjt